HDAd6/35++ - A new helper-dependent adenovirus vector platform for in vivo transduction of hematopoietic stem cells.

Wang H, Georgakopoulou A, Zhang W, Kim J, Gil S, Ehrhardt A, Lieber A

Open source

DOI
10.1016/j.omtm.2023.03.008
Published
2023 Jun 8
Container
Molecular therapy. Methods & clinical development
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omtm.2023.03.008,
  title = {HDAd6/35++ - A new helper-dependent adenovirus vector platform for in vivo transduction of hematopoietic stem cells.},
  author = {Wang H and Georgakopoulou A and Zhang W and Kim J and Gil S and Ehrhardt A and Lieber A},
  year = {2023},
  journal = {Molecular therapy. Methods \& clinical development},
  doi = {10.1016/j.omtm.2023.03.008},
  url = {https://doi.org/10.1016/j.omtm.2023.03.008}
}

RIS

TY  - JOUR
TI  - HDAd6/35++ - A new helper-dependent adenovirus vector platform for in vivo transduction of hematopoietic stem cells.
AU  - Wang H
AU  - Georgakopoulou A
AU  - Zhang W
AU  - Kim J
AU  - Gil S
AU  - Ehrhardt A
AU  - Lieber A
PY  - 2023
JO  - Molecular therapy. Methods & clinical development
DO  - 10.1016/j.omtm.2023.03.008
UR  - https://doi.org/10.1016/j.omtm.2023.03.008
ER  - 

APA

H, W., A, G., W, Z., J, K., S, G., A, E., & A, L. (2023). HDAd6/35++ - A new helper-dependent adenovirus vector platform for in vivo transduction of hematopoietic stem cells.. Molecular therapy. Methods & clinical development. https://doi.org/10.1016/j.omtm.2023.03.008

Source records